Molecular Solutions
Fast, accurate, and reliable molecular diagnostic kits represent a cornerstone in the modern healthcare landscape, offering a pivotal tool for the timely detection and management of various diseases. These kits, which leverage advanced molecular techniques such as polymerase chain reaction (PCR) , enable healthcare professionals to identify pathogens and genetic mutations with unprecedented speed and precision.
The Stark Genotyping HPV Molecular Diagnostic Kit is a comprehensive real-time PCR assay designed for the qualitative detection and genotyping of human papillomavirus (HPV) DNA in cervical, vaginal, urine, and FFPE tissue specimens.
The Stark MTB Molecular Diagnostic Kit sets the benchmark for precise and efficient detection of Mycobacterium tuberculosis (MTB) complex members, including M. tuberculosis, M. africanum, M. bovis, M. bovis BCG, M. microti, and M. pinnipedii.
The Stark Quantitative HBV Molecular Diagnostic Kit is a CE-marked real-time PCR solution designed for the precise quantification of hepatitis B virus (HBV) DNA in human EDTA plasma.
The Stark SARS-CoV-2 & Influenza A/B Molecular Diagnostic Kit is a high-performance multiplex RT-PCR assay designed for the simultaneous detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B viral RNA from clinical respiratory samples.
The Stark SARS-CoV-2 Molecular Diagnostic Kit is a ready-to-use real-time RT-PCR assay developed for the qualitative detection of SARS-CoV-2 RNA in respiratory specimens such as nasopharyngeal, oropharyngeal, nasal swabs, and saliva.